e-learning
resources
ERJ
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Tortoli Enrico, Russo Cristina, Piersimoni Claudio, Mazzola Ester, Dal Monte Paola, Pascarella Michela, Borroni Emanuele, Mondo Alessandra, Piana Federica, Scarparo Claudio, Coltella Luana, Lombardi Giulia, Cirillo Daniela M.
Source:
Eur Respir J 2012; 40: 442-447
Journal Issue:
August
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tortoli Enrico, Russo Cristina, Piersimoni Claudio, Mazzola Ester, Dal Monte Paola, Pascarella Michela, Borroni Emanuele, Mondo Alessandra, Piana Federica, Scarparo Claudio, Coltella Luana, Lombardi Giulia, Cirillo Daniela M.. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012; 40: 442-447
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Influence of COVID-19 pandemic on the main epidemiological dataof TB in Azerbaijan
What pulmonologists need to know about extrapulmonary tuberculosis
Non tuberculous mycobacterial pulmonary disease in the elderly
Related content which might interest you:
Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying
mycobacterium tuberculosis
during routine clinical practice
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Clinical utility of the Xpert MTB/RIF test in induced sputum
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Early tuberculosis treatment monitoring by Xpert® MTB/RIF
Source: Eur Respir J 2012; 39: 1269-1271
Year: 2012
Incremental Yield of Xpert MTB/RIF Ultra over Xpert MTB/RIF in the diagnosis of extra-pulmonary tuberculosis
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?
Source: Eur Respir J 2012; 40: 161-168
Year: 2012
A sputum sample processing method for community and mobile tuberculosis diagnosis using the Xpert MTB/RIF assay
Source: ERJ Open Res, 5 (1) 00165-2018; 10.1183/23120541.00165-2018
Year: 2019
Xpert MTB/RIF testing of pooled induced sputum
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis
Source: Eur Respir J 2013; 42: 708-720
Year: 2013
Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis
Source: Eur Respir J 2014; 44: 435-446
Year: 2014
Effect of history of tuberculosis on specificity of Xpert MTB/RIF
Source: Eur Respir J, 56 (3) 2000343; 10.1183/13993003.00343-2020
Year: 2020
The yield of bronchoscopy in sputum Xpert MTB/Rif negative tuberculosis in the Xpert era.
Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Year: 2020
Study of diagnostic sensitivity for mycobacterium tuberculosis(MTB) by smear, culture and Xpert MTB/RIF assay in pleural specimens obtained by medical thoracoscopy.
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Performance of Xpert MTB/RIF Ultra for tuberculosis diagnosis in the context of passive and active case finding
Source: Eur Respir J, 58 (6) 2100257; 10.1183/13993003.00257-2021
Year: 2021
Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India
Source: Eur Respir J 2014; 44: 1090-1093
Year: 2014
Rapid diagnosis of tuberculosis and rifampin resistance by GeneXpert MTB/RIF test
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
Performance of Xpert MTB/RIF on pleural tissue for the diagnosis of pleural tuberculosis
Source: Eur Respir J 2013; 42: 1427-1429
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept